A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities

Eur J Cancer. 1995;31A(1):58-63. doi: 10.1016/0959-8049(94)00372-c.

Abstract

The aim of this study was to investigate the role of mild hyperthermia (39-40 degrees C) in isolated cytostatic perfusion for patients with recurrent melanoma of the extremities. A total of 218 patients treated with mild hyperthermic perfusion was compared to 166 patients perfused under controlled normothermic conditions (37-38 degrees C). Only patients whose lesions had been excised before or at the moment of perfusion were eligible for this study. A variety of prognostic factors was controlled for in a Cox proportional hazards analysis. The application of mild hyperthermia did not influence limb recurrence-free interval nor survival (corrected P values 0.46 and 0.18, respectively). In this retrospective comparative study, no benefit for mild hyperthermia in regional isolated perfusion could be identified.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chemotherapy, Cancer, Regional Perfusion / methods*
  • Disease-Free Survival
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Melanoma / surgery
  • Melphalan / administration & dosage
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Prognosis
  • Retrospective Studies

Substances

  • Melphalan